Polyphenols are medicine: Is it time to prescribe red wine for our patients?

International Journal of Angiology

Volumn 18, Issue 3, 2009, Pages 111-117

  Cordova, Alfredo C ^a   Sumpio, Bauer E ^b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; French Paradox; Polyphenols; Red wine

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POLYPHENOL;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; BONE DENSITY; CANCER INCIDENCE; CANCER PREVENTION; CARDIOVASCULAR DISEASE; COGNITION; COMPARATIVE STUDY; DIET THERAPY; DISEASE ASSOCIATION; FIBRINOLYSIS; FOOD COMPOSITION; HEART PROTECTION; HUMAN; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RED WINE; REVIEW; RISK REDUCTION; SMOKING; STONE FORMATION; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR DISEASE; VASODILATATION;

EID: 80052987906     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278336     Document Type: Review

References (80)

1. American Heart Association/American Stroke Association. Heart Disease and Stroke Statistics - 2005 Update. (Version current at December 4, 2009).
2. Hutchinson AB, Farnham PG, Dean HD, et al. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: Evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr 2006;43:451-7. (Pubitemid 44737104)
3. World Health Organization. Cardiovascular diseases. (Version current at December 4, 2009).
4. St Leger AS, Cochrane AL, Moore F. Factors associated with cardiomortality in developed countries with particular reference to consumption of wine. Lancet 1979;1:1017-20. (Pubitemid 9183433)
5. Klatsby AL, Friedman GD, Siegalub AB. Alcohol consumption before myocardial infarction. Ann Intern Med 1974;81:294-301.
6. Hennekens CH, Robner B, Cole D. Daily alcohol consumption and fatal coronary heart disease. Am J Epidemiol 1978;107:196-200. (Pubitemid 8313529)
7. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
8. Heberden W. Some account of a disorder of the breast. Med Trans R Coll Physicians (London) 1786;2:59-67.
9. Klatsky AL. Alcohol and cardiovascular diseases: A historical overview. Ann NY Acad Sci 2002;957:7-15. (Pubitemid 34721649)
10. Cabot RC. The relation of alcohol to arteriosclerosis. J Am Med Assoc 1904;43:774-5.
11. Yano K, Rhoads GG, Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. New Engl J Med 1977;297:405-9. (Pubitemid 8197450)
12. World Health Organization. WHO MONICA Project. MONICA Manual. (Version current at January 13, 2010).
13. Vinson JA, Teufel K, Wu N. Red wine, dealcoholized red wine, and especially grape juice inhibit atherosclerosis in a hamster model. Atherosclerosis 2001;156:67-72. (Pubitemid 32429596)
14. Kozararevic D, Mc Gee D, Vojvodic N, Racic Z, Dawber T, Gordon T. Frequency of alcohol consumption and morbidity and mortality. Lancet 1980;1:613-6.
15. Marmot MG, Rose G, Shipley MJ, Thomas BJ. Alcohol and mortality: Explaining the U-shaped curve. Lancet 1981;1:580-3. (Pubitemid 11138317)
16. Shaper AG, Wattamethee G, Walker M. Alcohol and mortality in British men: Explaining the U-shaped curve. Lancet 1988;1:1267-73.
17. Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990;1:337-9.
18. Mukamal KJ, Conigraves KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease. N Engl J Med 2003;348:109-18. (Pubitemid 36056717)
19. Rimm EB, Giovannucci FL, Willet WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-86.
20. Stampfer MJ, Colditz GA, Willet WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1998;319:267-73.
21. Bell J, Donnovan J, Wong R, et al. (+)-catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr 2000;71:103-8. (Pubitemid 30033591)
22. Goldberg DM, Hahn SE, Parkes JG. Beyond alcohol: Beverage consumption and cardiovascular mortality. Clin Chim Acta 1995;237:155-87.
23. Fuhrman B, Aviram M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 2001;12:41-8. (Pubitemid 32121284)
24. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998;68:258-65. (Pubitemid 28355641)
25. Criqui MH, Ringel BL. Does diet or alcohol explain the French Paradox? Lancet 1994;344:1719-23.
26. Klatsky AL, Armstrong MA Alcoholic beverage choice and risk of coronary heart disease mortality: Do red wine drinkers fare best? Am J Cardiol 193;71:467-469 (Pubitemid 23061522)
27. Klatsky AL, Armstrong MA, Freedman GD. Relation of alcoholic beverage use to subsequent coronary heart disease hospitalization. Am J Cardiol 1986;58:710-4. (Pubitemid 17004231)
28. Gronbaek M, Deis A. Sorensen TI, Beker U, Schnoh P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995;310:1165-9.
29. Groønbaek M, Becker U, Johansen D, et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000;133:411-9.
30. Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: History, production, and role in disease prevention. J Clin Lab Anal 1997;11:287-313. (Pubitemid 27371787)
31. De Lange DW. From red wine to polyphenols and back: A journey through the history of the French Paradox. Thromb Res 2007;119:403-6.
32. Waterhouse AL. Wine phenolics. Ann N Y Acad Sci 2002;957:21-36. (Pubitemid 34721651)
33. Alvarez-Sala L, Slowing K, Gomez-Serranillos P, Torres F, Valderrama M, Millan J. Variabilidad del contenido de polifenoles de distintos tipos de vino y su potencial aplicación al conocimiento de sus efectos biologicos. Med Clin (Barc) 2000;114:331-2.
34. Kennedy JA, Matthews MA, Waterhouse AL. Changes in grape seed polyphenols during fruit ripening. Phytochemistry 2000;55:77-85.
35. Price SF, Breen PJ, Valladao M, Watson BT. Cluster sun exposure and quercetin in pinot noir grapes and wine. Am J Enol Vitic 1995;46:187-94.
36. Van Acker S, Van-den Berg DJ, Tromp M, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996;20:331-42. (Pubitemid 26077855)
37. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidants activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56. (Pubitemid 26157509)
38. Vinson JA, Hontz BA. Phenol antioxidant index: Comparative antioxidant effectiveness of red and white wines. J Agric Food Chem 1995;43:401-3.
39. Fuhrman B, Volkova N, Suraski A, Aviram M. White wine with red wine-like properties: Increased extraction of grape skin polyphenols improve the antioxidant capacity of the derived white wine. J Agric Food Chem 2001;49:3164-8.
40. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998;68:258-65. (Pubitemid 28355641)
41. Brenna O, Pagliarini E. Multivariate analysis of antioxidant power and polyphenolic composition in red wines. J Agric Food Chem 2001;49:4841-4. (Pubitemid 32988728)
42. Waterhouse AL, German J, Walzem R, Hansen R, Kasim-Karakas S. Is it time for a wine trial? Am J Clin Nutr 1998;68:220-1. (Pubitemid 28355634)
43. Abu-Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum low-density lipoprotein oxidation in vitro: Identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin Sci (Lond) 1996;91:449-58. (Pubitemid 26336528)
44. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
45. Zou J, Huang Y, Chen Q, Wei E, Cao K, Wu JM. Effect of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J (Engl) 2000;113:99-102. (Pubitemid 30176438)
46. Perret B, Ruidavets JB, Vieu C, et al. Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate. Alcohol Clin Exp Res 2002;26:1134-40. (Pubitemid 34913198)
47. Araya J, Rodrigo R, Orellana M, Rivera G. Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes. Br J Nutr 2001;86:189-95. (Pubitemid 32780624)
48. Ruf JC, Berger JL, Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Arterioscler Thromb Vasc Biol 1995;15:140-4.
49. Micallef M, Lexis L, Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J 2007;6:27.
50. Mondun D, Music I, Vukovic J, et al. The increase in human plasma antioxidant capacity after red wine consumption is due to both plasma urate and wine polyphenols. Atherosclerosis 2008;197:250-6. (Pubitemid 351273246)
51. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996;246:163-82. (Pubitemid 26094547)
52. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 1995;236:207-19.
53. Perret B, Ruidavets JB, Vieu C, et al. Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate. Alcohol Clin Exp Res 2002;26:1134-40. (Pubitemid 34913198)
54. Araya J, Rodrigo R, Orellana M, Rivera G. Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes. Br J Nutr 2001;86:189-95. (Pubitemid 32780624)
55. Carluccio MA, Siculella L, Ancora MA, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: Antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 2003;23:622-9. (Pubitemid 36438075)
56. Sacanella E, Vasques-Agell M, Mena MP, et al. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: A randomized trial. Am J Clin Nutr 2007;86:1463-9. (Pubitemid 350126252)
57. Gresele P, Pignatelli P, Guglielmini G, et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 2008;138:1602-8.
58. De Lorimier AA. Alcohol, wine, and health. Am J Surg 2000;180:357-61. (Pubitemid 32011318)
59. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997;45:273-6.
60. Gronbaek M, Becker U, Johansen D, et al. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ 1998;317:844-7.
61. Vioque J, Barber X, Bolumar F, et al. Esophageal cancer risk by type of alcohol drinking and smoking: A case-control study in Spain. BMC Cancer 2008;8:221.
62. Bushman JL. Green tea and cancer: A review of the literature. Nutr Cancer 1998;31:151-9. (Pubitemid 28481848)
63. Marimon JM, Bujando L, Gutierrez-Stampa MA, et al. In vitro bactericidal effects of wine against Helicobacter pylori. Am J Gastroenterol 1998;93:1392. (Pubitemid 29076959)
64. Brenner H, Rotherbacher D, Bode G, et al. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: Cross sectional study. BMJ 1997;315:1489-92. (Pubitemid 27517174)
65. Aldoori WH, Giovannucci EL, Stamfer MJ, et al. A prospective study of alcohol, smoking, caffeine, and he risk of duodenal ulcer in men. Epidemiology 1997;8:420-4. (Pubitemid 27274229)
66. Cohen S, Tyrell DAJ, Russel MAH, et al. Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health 1993;83:1277-83. (Pubitemid 23262033)
67. Simon JA, Grady D, Snabes MC, et al. Ascorbic acid supplement and use to prevent gallbladder disease. J Clin Epidemiol 1998;51:27-65.
68. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-7. (Pubitemid 26032629)
69. Curhan GC, Willett WC, Speizer FE, et al. Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128:534-40. (Pubitemid 28177660)
70. Obisesan TO, Hirsch R, Kosoko O, et al. Moderate wine consumption is associated with decreased odds of developing agerelated macular degeneration in NHANES-1. J Am Geriatr Soc 1988;46:1-7.
71. Burger H, de Laet CE, van Daele PL, et al. Risk factors for increased bone loss in an elderly population: The Rotterdam Study. Am J Epidemiol 1998;147:871-9.
72. Hoøidrup S, Groønbaek M, Gottschau A, Lauritzen JB, Schroll M. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 1999;149:993-1001. (Pubitemid 29246863)
73. Launer LJ, Feskens EJ, Kalmijn S, Kromhout D. Smoking, drinking, and thinking. The Zutphen Elderly Study. Am J Epidemiol 1996;143:219-27.
74. Orgogozo J-M, Dartigues J-F, Lafont S, et al. Wine consumption and dementia in the elderly: A proseptive community study in the Bordeaux area. Rev Neurol 1997;153:185-92. (Pubitemid 27262834)
75. Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998;44:95-105.
76. Elias PK, Elias MF, D'Agostino RB, Silbershatz H, Wolf PA. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol 1999;150:580-9. (Pubitemid 29426902)
77. Cordova AC, Jackson LS, Berke-Schlessel DW, Sumpio BE. The cardiovascular protective effect of red wine. J Am Coll Surg 2005;200:428-39. (Pubitemid 40298978)
78. Global Market Information Database. 2002. (Version current at January 13, 2010).
79. OECD Health Data 2005. Paris: Organisation for Economic Co-operation and Development, 2005.
80. World Health Organization. World Health Statistics 2008. (Version current at December 4, 2009).